SolarEdge’s Technology First to Meet South Australia’s New Dynamic Export Regulations
SA Power Networks is the first Australian electricity distribution network to set Dynamic Export requirements…
Month: January 2023
CORRECTING and REPLACING Kinder Morgan to Hold 2023 Investor Day
HOUSTON–(BUSINESS WIRE)–CORRECTION ON TIME: Second paragraph, third sentence of release should read: Live presentations are…
Dwight Capital and Dwight Mortgage Trust End 2022 with Over $3 Billion in Financing
Dwight Capital Consistently Tops the Commercial Lender Rankings NEW YORK–(BUSINESS WIRE)–Dwight Capital and its affiliate…
Citrine Informatics Appoints CCO Scott Carlyle
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Citrine Informatics is proud to announce the appointment of Scott Carlyle as…
OIF Marks 25th Anniversary, Launches New Physical & Link Layer Working Group Electrical Project and Adds 112G VSR Clause to CEI 5.0 IA at Q1 Technical and MA&E Committees Meeting
The meeting hosted leading analysts from 650 Group and LightCounting as guest speakers giving member…
OIF Marks 25th Anniversary, Launches New Physical & Link Layer Working Group Electrical Project and Adds 112G VSR Clause to CEI 5.0 IA at Q1 Technical and MA&E Committees Meeting
The meeting hosted leading analysts from 650 Group and LightCounting as guest speakers giving member…
Kingston Technology Server Premier DDR5 4800MT/s Registered DIMMs Receive Validation on 4th Gen Intel Xeon Scalable Processor
FOUNTAIN VALLEY, Calif.–(BUSINESS WIRE)–Kingston Technology Company, Inc., a world leader in memory products and technology…
Qualigen Therapeutics Promotes Benedict M. Abugan to Vice President, Head of Diagnostics and Corporate Communications
Qualigen Therapeutics, Inc. Benedict M. Abugan CARLSBAD, Calif., Jan. 23, 2023 (GLOBE NEWSWIRE) — Qualigen…
AltruBio Announces First Patient Dosed in Phase 1 Trial of Next-Generation Immune Checkpoint Enhancer ALTB-268 for the Treatment of Ulcerative Colitis
SAN FRANCISCO, Jan. 23, 2023 (GLOBE NEWSWIRE) — AltruBio Inc. (“AltruBio” or “the Company”), a…
Sofwave Gains Market Approval For SUPERB™ Non-Invasive Wrinkle Reduction and Lifting Technology in Mexico — the Second Largest Aesthetic Medical Market in Latin America
Approval granted by Mexico’s Food and Drug Administration, the Federal Commission for the Protection from…
RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
Glen Rock, N.J., Jan. 23, 2023 (GLOBE NEWSWIRE) — RespireRx Pharmaceuticals Inc. (OTC Markets: RSPI)…
Clinigen divests Proleukin® to Iovance Biotherapeutics for £166.7 million
23 January 2023 Clinigen divests Proleukin® to Iovance Biotherapeutics for £166.7 million The deal includes…
Catalyst Pharmaceuticals Notified of Abbreviated New Drug Application Filing for FIRDAPSE®
CORAL GABLES, Fla., Jan. 23, 2023 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (NASDAQ: CPRX),…
Iovance Biotherapeutics Provides Corporate, Clinical, and Regulatory Updates
Acquisition of Worldwide Rights to Proleukin® Provides Immediate and Ongoing Revenue and Secures IL-2 Supply…
Aerovate Therapeutics Appoints Donald Santel To Its Board of Directors
WALTHAM, Mass., Jan. 23, 2023 (GLOBE NEWSWIRE) — Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical-stage…
CytoReason to License Its IBD Disease Model to Sanofi in Expanded Multiyear, Multimillion Dollar Deal
Collaboration will support Sanofi’s use of CytoReason’s computational disease models to develop new targets for…
Cue Biopharma Announces Chief Medical Officer Transition
Matteo Levisetti, M.D., promoted to Chief Medical Officer, effective January 17, 2023 Acting CMO Kenneth…
IO Biotech Announces Appointment of Devin Smith as General Counsel
Mr. Smith joins IO Biotech bringing over two decades of legal and compliance experience in…
Rhythm Pharmaceuticals Announces Publication of Analysis of Quality of Life Improvements from Phase 3 Clinical Trial in Bardet-Biedl Syndrome
– Patients reported clinically meaningful improvements across multiple health-related quality of life measures following 52…
Dr. Matt Cahill Appointed Chief Operating Officer of Qu Biologics
BURNABY, British Columbia, Jan. 23, 2023 (GLOBE NEWSWIRE) — Qu Biologics Inc., a clinical stage…